Comprehensive analysis of inhibitory checkpoint ligand expression by glioblastoma cells-Reference-Cited by-同舟云学术

Comprehensive analysis of inhibitory checkpoint ligand expression by glioblastoma cells

Published:2020-12-28 Issue:4 Volume:99 Page:403-418
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol. Cell Biol.

Author:

Robilliard Laverne D¹²^ORCID,Yu Jane¹²,Anchan Akshata¹²^ORCID,Joseph Wayne³,Finlay Graeme¹³,Angel Catherine E⁴⁵^ORCID,Scott Graham E¹²^ORCID

Affiliation:

1. Department of Molecular Medicine and Pathology School of Medical Sciences Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand

2. Centre for Brain Research University of Auckland Auckland New Zealand

3. Auckland Cancer Society Research Centre University of Auckland Auckland New Zealand

4. School of Biological Sciences Faculty of Science University of Auckland Auckland New Zealand

5. Maurice Wilkins Centre for Molecular Biodiscovery University of Auckland Auckland New Zealand

Funder

Neurological Foundation of New Zealand

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12428

Reference61 articles.

1. Heterogeneity Maintenance in Glioblastoma: A Social Network: Figure 1.

2. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas;Shapiro JR;Cancer Res,1981

3. Identification of human brain tumour initiating cells

4. Cancer stem cells: Cell culture, markers, and targets for new therapies

5. Cancer stem cells in glioblastoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29

2. Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications;Advances in Cancer Biology - Metastasis;2023-10

3. Natural and synthetic compounds for glioma treatment based on ROS-mediated strategy;European Journal of Pharmacology;2023-08

4. Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes;International Journal of Molecular Sciences;2022-11-16

5. A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas;International Journal of Genomics;2022-11-14